Physiomics (PYC) Competitors GBX 0.57 +0.02 (+2.90%) As of 09:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock PYC vs. GENF, SNG, BVX, OBD, and NFXShould you buy Physiomics stock or one of its competitors? MarketBeat compares Physiomics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Physiomics include Genflow Biosciences (GENF), Synairgen (SNG), BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), and Nuformix (NFX). These companies are all part of the "biotechnology" industry. PYC vs. GENFPYC vs. SNGPYC vs. BVXPYC vs. OBDPYC vs. NFXHow does Physiomics compare to Genflow Biosciences?Physiomics (LON:PYC) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership. Does the media prefer PYC or GENF? In the previous week, Physiomics had 1 more articles in the media than Genflow Biosciences. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Genflow Biosciences. Physiomics' average media sentiment score of 0.26 beat Genflow Biosciences' score of 0.00 indicating that Physiomics is being referred to more favorably in the media. Company Overall Sentiment Physiomics Neutral Genflow Biosciences Neutral Is PYC or GENF more profitable? Genflow Biosciences has a net margin of 840.76% compared to Physiomics' net margin of -50.92%. Genflow Biosciences' return on equity of 377.33% beat Physiomics' return on equity.Company Net Margins Return on Equity Return on Assets Physiomics-50.92% -89.43% -76.38% Genflow Biosciences 840.76%377.33%-58.66% Which has better valuation and earnings, PYC or GENF? Physiomics has higher revenue and earnings than Genflow Biosciences. Genflow Biosciences is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhysiomics£953.01K2.70-£922.82K-£0.15N/AGenflow BiosciencesN/AN/A-£1.76M-£0.33N/A Which has more volatility & risk, PYC or GENF? Physiomics has a beta of 0.946, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Genflow Biosciences has a beta of 2.108, indicating that its stock price is 111% more volatile than the broader market. Do institutionals and insiders have more ownership in PYC or GENF? 0.8% of Physiomics shares are held by institutional investors. Comparatively, 0.1% of Genflow Biosciences shares are held by institutional investors. 4.9% of Physiomics shares are held by company insiders. Comparatively, 47.5% of Genflow Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryPhysiomics beats Genflow Biosciences on 7 of the 12 factors compared between the two stocks.How does Physiomics compare to Synairgen?Synairgen (LON:SNG) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk. Which has more volatility and risk, SNG or PYC? Synairgen has a beta of -2.23, suggesting that its share price is 323% less volatile than the broader market. Comparatively, Physiomics has a beta of 0.946, suggesting that its share price is 5% less volatile than the broader market. Does the media prefer SNG or PYC? In the previous week, Physiomics had 1 more articles in the media than Synairgen. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Synairgen. Physiomics' average media sentiment score of 0.26 beat Synairgen's score of 0.00 indicating that Physiomics is being referred to more favorably in the news media. Company Overall Sentiment Synairgen Neutral Physiomics Neutral Which has stronger valuation and earnings, SNG or PYC? Physiomics has higher revenue and earnings than Synairgen. Physiomics is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynairgenN/AN/A-£15.86M-£1.66N/APhysiomics£953.01K2.70-£922.82K-£0.15N/A Is SNG or PYC more profitable? Synairgen has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Synairgen's return on equity of -51.06% beat Physiomics' return on equity.Company Net Margins Return on Equity Return on Assets SynairgenN/A -51.06% -30.58% Physiomics -50.92%-89.43%-76.38% Do institutionals and insiders have more ownership in SNG or PYC? 30.7% of Synairgen shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 3.2% of Synairgen shares are held by insiders. Comparatively, 4.9% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryPhysiomics beats Synairgen on 7 of the 12 factors compared between the two stocks.How does Physiomics compare to BiVictriX Therapeutics?Physiomics (LON:PYC) and BiVictriX Therapeutics (LON:BVX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk. Does the media prefer PYC or BVX? In the previous week, Physiomics had 1 more articles in the media than BiVictriX Therapeutics. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for BiVictriX Therapeutics. Physiomics' average media sentiment score of 0.26 beat BiVictriX Therapeutics' score of 0.00 indicating that Physiomics is being referred to more favorably in the media. Company Overall Sentiment Physiomics Neutral BiVictriX Therapeutics Neutral Which has higher earnings and valuation, PYC or BVX? Physiomics has higher revenue and earnings than BiVictriX Therapeutics. Physiomics is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhysiomics£953.01K2.70-£922.82K-£0.15N/ABiVictriX TherapeuticsN/AN/A-£2.67M-£0.04N/A Do institutionals and insiders hold more shares of PYC or BVX? 0.8% of Physiomics shares are owned by institutional investors. Comparatively, 30.8% of BiVictriX Therapeutics shares are owned by institutional investors. 4.9% of Physiomics shares are owned by company insiders. Comparatively, 42.6% of BiVictriX Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is PYC or BVX more profitable? BiVictriX Therapeutics has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Physiomics' return on equity of -89.43% beat BiVictriX Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Physiomics-50.92% -89.43% -76.38% BiVictriX Therapeutics N/A -103.99%-62.99% Which has more volatility and risk, PYC or BVX? Physiomics has a beta of 0.946, indicating that its stock price is 5% less volatile than the broader market. Comparatively, BiVictriX Therapeutics has a beta of -0.73, indicating that its stock price is 173% less volatile than the broader market. SummaryPhysiomics beats BiVictriX Therapeutics on 7 of the 12 factors compared between the two stocks.How does Physiomics compare to Oxford BioDynamics?Oxford BioDynamics (LON:OBD) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment. Which has better earnings & valuation, OBD or PYC? Physiomics has lower revenue, but higher earnings than Oxford BioDynamics. Physiomics is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxford BioDynamics£1.10M7.68-£103.52M-£0.80N/APhysiomics£953.01K2.70-£922.82K-£0.15N/A Is OBD or PYC more profitable? Physiomics has a net margin of -50.92% compared to Oxford BioDynamics' net margin of -1,018.54%. Physiomics' return on equity of -89.43% beat Oxford BioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Oxford BioDynamics-1,018.54% -316.67% -56.23% Physiomics -50.92%-89.43%-76.38% Does the media favor OBD or PYC? In the previous week, Physiomics had 1 more articles in the media than Oxford BioDynamics. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Oxford BioDynamics. Physiomics' average media sentiment score of 0.26 beat Oxford BioDynamics' score of 0.00 indicating that Physiomics is being referred to more favorably in the news media. Company Overall Sentiment Oxford BioDynamics Neutral Physiomics Neutral Which has more risk & volatility, OBD or PYC? Oxford BioDynamics has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market. Comparatively, Physiomics has a beta of 0.946, meaning that its share price is 5% less volatile than the broader market. Do institutionals and insiders have more ownership in OBD or PYC? 25.4% of Oxford BioDynamics shares are owned by institutional investors. Comparatively, 0.8% of Physiomics shares are owned by institutional investors. 15.6% of Oxford BioDynamics shares are owned by company insiders. Comparatively, 4.9% of Physiomics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryPhysiomics beats Oxford BioDynamics on 7 of the 13 factors compared between the two stocks.How does Physiomics compare to Nuformix?Physiomics (LON:PYC) and Nuformix (LON:NFX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings. Does the media prefer PYC or NFX? In the previous week, Physiomics had 1 more articles in the media than Nuformix. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Nuformix. Physiomics' average media sentiment score of 0.26 beat Nuformix's score of 0.00 indicating that Physiomics is being referred to more favorably in the media. Company Overall Sentiment Physiomics Neutral Nuformix Neutral Which has more volatility & risk, PYC or NFX? Physiomics has a beta of 0.946, indicating that its share price is 5% less volatile than the broader market. Comparatively, Nuformix has a beta of 1.545, indicating that its share price is 55% more volatile than the broader market. Do insiders & institutionals have more ownership in PYC or NFX? 0.8% of Physiomics shares are owned by institutional investors. Comparatively, 0.1% of Nuformix shares are owned by institutional investors. 4.9% of Physiomics shares are owned by insiders. Comparatively, 9.3% of Nuformix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is PYC or NFX more profitable? Nuformix has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Nuformix's return on equity of -83.53% beat Physiomics' return on equity.Company Net Margins Return on Equity Return on Assets Physiomics-50.92% -89.43% -76.38% Nuformix N/A -83.53%-17.20% Which has preferable earnings and valuation, PYC or NFX? Nuformix has lower revenue, but higher earnings than Physiomics. Nuformix is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhysiomics£953.01K2.70-£922.82K-£0.15N/ANuformixN/AN/A-£383.40K-£0.04N/A SummaryNuformix beats Physiomics on 7 of the 12 factors compared between the two stocks. Get Physiomics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYC vs. The Competition ExportMetricPhysiomicsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.57M£462.13M£6.29B£2.77BDividend Yield6.20%3.86%2.80%6.15%P/E Ratio-3.793.8020.62365.17Price / Sales2.707,455.24545.5887,687.40Price / Cash4.2113.1327.4827.89Price / Book2.7284.129.737.65Net Income-£922.82K-£96.07M£3.55B£5.89B7 Day Performance-12.62%0.84%-1.86%0.12%1 Month Performance20.85%0.12%-3.69%0.31%1 Year Performance35.89%69.11%29.52%83.58% Physiomics Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYCPhysiomicsN/AGBX 0.57+2.9%N/A+37.6%£2.57M£953.01KN/A10Gap UpGENFGenflow BiosciencesN/AGBX 2.20-4.3%N/A+118.8%£11.78MN/AN/A5High Trading VolumeSNGSynairgenN/AN/AN/AN/A£9.04MN/AN/A34Gap DownBVXBiVictriX TherapeuticsN/AN/AN/AN/A£8.25MN/AN/A17Gap UpHigh Trading VolumeOBDOxford BioDynamicsN/AGBX 0.19+2.7%N/A-51.7%£8.15M£1.10MN/A45Gap Down Related Companies and Tools Related Companies Genflow Biosciences Competitors Synairgen Competitors BiVictriX Therapeutics Competitors Oxford BioDynamics Competitors Nuformix Competitors OptiBiotix Health Competitors Theracryf Competitors Talisman Metals Competitors Futura Medical Competitors Evgen Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PYC) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
